Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2017-12-12 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MEYZIEU (69330), Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE NOUVELLE DES PLANTEES : revenue, balance sheet and financial ratios
PHARMACIE NOUVELLE DES PLANTEES is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MEYZIEU (69330),
this company of category PME
shows in 2024 a net income positive of 208 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE NOUVELLE DES PLANTEES (SIREN 834323297)
Indicator
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
208 418 €
247 480 €
310 061 €
330 961 €
255 075 €
199 241 €
164 556 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE NOUVELLE DES PLANTEES generates positive net income of 208 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 165 k€ -> 208 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
208 418 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 80%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 48%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
79.587%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.139%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE NOUVELLE DES PLANTEES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
Debt ratio
1834.728
787.296
429.721
251.991
145.004
99.5
79.587
Financial autonomy
4.583
9.882
16.747
25.029
34.416
41.894
48.139
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
79.592024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average-11 pts over 3 years
In 2024, the debt ratio of PHARMACIE NOUVELLE DES PL... (79.59) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.14%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+15 pts over 3 years
In 2024, the financial autonomy of PHARMACIE NOUVELLE DES PL... (48.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 148.90. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
148.899
Liquidity indicators evolution PHARMACIE NOUVELLE DES PLANTEES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
218.653
193.498
221.677
233.592
168.497
156.527
148.899
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
148.92024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average
In 2024, the liquidity ratio of PHARMACIE NOUVELLE DES PL... (148.90) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE NOUVELLE DES PLANTEES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE NOUVELLE DES PLANTEES is estimated at
2 909 669 €
(range 2 026 247€ - 4 353 031€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2026k€2909k€4353k€
2 909 669 €Range: 2 026 247€ - 4 353 031€
NAF 5 année 2024
Valuation method used
Net Income Multiple
208 418 €
×
14.0x
=2 909 669 €
Range: 2 026 248€ - 4 353 032€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE NOUVELLE DES PLANTEES with other companies in the same sector:
Frequently asked questions about PHARMACIE NOUVELLE DES PLANTEES
What is the revenue of PHARMACIE NOUVELLE DES PLANTEES ?
The revenue of PHARMACIE NOUVELLE DES PLANTEES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE NOUVELLE DES PLANTEES profitable?
Yes, PHARMACIE NOUVELLE DES PLANTEES generated a net profit of 208 k€ in 2024.
Where is the headquarters of PHARMACIE NOUVELLE DES PLANTEES ?
The headquarters of PHARMACIE NOUVELLE DES PLANTEES is located in MEYZIEU (69330), in the department Rhone.
Where to find the tax return of PHARMACIE NOUVELLE DES PLANTEES ?
The tax return of PHARMACIE NOUVELLE DES PLANTEES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE NOUVELLE DES PLANTEES operate?
PHARMACIE NOUVELLE DES PLANTEES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart